Our study establishes the prognostic signature of IFN-γ-related lncRNAs for the first time, in which the grouping of endometrial cancer patients not only can guide prognostic assessment but also can help in understanding the differences in the immune microenvironment. The gene discussed is IFNG; the disease is endometrial cancer.